Arcus Biosciences's market cap is currently $1.37B. The company's EPS TTM is $0; its P/E ratio is ―; Arcus Biosciences is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-1.28. See an overview of income statement, balance sheet, and cash flow financials.
